ArticleEndocrine-related cancer2014

Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer.

Zongjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.